|
1 Indications And Usage Emend ® For Injection, In Combination With Other Antiemetic Agents, Is Indicated In Adults And Pediatric Patients 6 Months Of Age And Older For The Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin. Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec). Emend ® For Injection Is A Substance P/neurokinin-1 (Nk 1 ) Receptor Antagonist, Indicated In Adults And Pediatric Patients 6 Months Of Age And Older, In Combination With Other Antiemetic Agents, For The Prevention Of ( 1 ): Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin. Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec). Limitations Of Use ( 1 ) Emend Has Not Been Studied For Treatment Of Established Nausea And Vomiting. Limitations Of Use Emend Has Not Been Studied For The Treatment Of Established Nausea And Vomiting.
|